Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage

Mutations in the transcription factor SOX10 cause neurocristopathies, including Waardenburg-Hirschsprung syndrome and peripheral neuropathies in humans. This is partly attributed to a requirement for Sox10 in early neural crest for survival, maintenance of pluripotency, and specification to several...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 189; no. 4; pp. 701 - 712
Main Authors Finzsch, Markus, Schreiner, Silke, Kichko, Tatjana, Reeh, Peter, Tamm, Ernst R, Bösl, Michael R, Meijer, Dies, Wegner, Michael
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 17.05.2010
Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mutations in the transcription factor SOX10 cause neurocristopathies, including Waardenburg-Hirschsprung syndrome and peripheral neuropathies in humans. This is partly attributed to a requirement for Sox10 in early neural crest for survival, maintenance of pluripotency, and specification to several cell lineages, including peripheral glia. As a consequence, peripheral glia are absent in Sox10-deficient mice. Intriguingly, Sox10 continues to be expressed in these cells after specification. To analyze glial functions after specification, we specifically deleted Sox10 in immature Schwann cells by conditional mutagenesis. Mutant mice died from peripheral neuropathy before the seventh postnatal week. Nerve alterations included a thinned perineurial sheath, increased lipid and collagen deposition, and a dramatically altered cellular composition. Nerve conduction was also grossly aberrant, and neither myelinating nor nonmyelinating Schwann cells formed. Instead, axons of different sizes remained unsorted in large bundles. Schwann cells failed to develop beyond the immature stage and were unable to maintain identity. Thus, our study identifies a novel cause for peripheral neuropathies in patients with SOX10 mutations.
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200912142